Nuveen Asset Management, LLC Aptinyx Inc. Transaction History

Nuveen Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$2.39 - $3.5 $447,302 - $655,046	-187,156 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.86 - $4.33 $77,817 - $117,814	27,209 Added 17.01%	187,156 $561,000
Q4 2020 Feb 16, 2021	BUY	$2.93 - $4.3 $5,508 - $8,084	1,880 Added 1.19%	159,947 $553,000
Q3 2020 Nov 16, 2020	BUY	$3.05 - $4.99 $62,186 - $101,741	20,389 Added 14.81%	158,067 $534,000
Q2 2020 Aug 14, 2020	BUY	$1.99 - $4.4 $273,979 - $605,783	137,678 New	137,678 $574,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.